Invention Grant
- Patent Title: PTPN11 inhibitors
-
Application No.: US17380943Application Date: 2021-07-20
-
Publication No.: US11945815B2Publication Date: 2024-04-02
- Inventor: Philip Jones , Barbara Czako , Christopher L Carroll , Pijus Mandal , Jason Cross
- Applicant: NAVIRE PHARMA, INC.
- Applicant Address: US CA Palo Alto
- Assignee: NAVIRE PHARMA, INC.
- Current Assignee: NAVIRE PHARMA, INC.
- Current Assignee Address: US CA Palo Alto
- Agency: Mintz, Levin, Cohn, Ferris Glovsky & Popeo, P.C.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00 ; C07D491/107
Abstract:
The present invention relates to compounds which are useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Information query
